A Phase I/II Study of MGCD0103 (MG-0103) in Combination With Gemcitabine
Clinical trial NCT00372437 · COMPLETED
Trial details
- NCT number
- NCT00372437
- Sponsor
- Mirati Therapeutics Inc.
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2006-09-01
- Primary completion
- 2008-12-01
- Enrollment
- 47
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.